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INTRODUCTION
As a nonclassical bioisostere of the pyridine 
ring, the nitroaromatic structural motif may be 
found in a great number of artificial pharmaceuti-
cals (Clonazepam, Flunitrazepam, Nitrazepam, Enta-
capone, Flutamide, Nifedipine, Nilutamide, Nifurox-
azide, Nitrofurantoin, Metronidazole, etc., as well as 
the present examined Nitrofural medicine) (1,2).
As a part of overall pharmacopoeial analysis, 
the qualitative control of nitroaromatic raw materi-
als (medicines) is a task of paramount analytical im-
portance. As a rule, the qualitative pharmacopoeial 
ABSTRACT
The present study deals with the development of a new qualitative electrochemical analytic test for detect-
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and electric power, provided by a 9V battery, was successfully implemented for the analysis of the medicine 
in question. 
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analysis is intended to confirm the identity of phar-
maceutical raw materials at the so-assigned “accept-
able” level of assurance (at the “second identification” 
stage). One of the positives of this analytical approach 
is its allowing a visual indication (analytical confir-
mation) of the chemical composition of the drug an-
alyzed in toto or, partially of its peculiar structural 
motif (3-5). Therefore, in particular nowadays, the 
pharmacopoeial qualitative analysis is being wide-
ly used as a powerful analytical „instrument“ for the 
identification of many drug raw materials, including 
the one examined here (2,4).
The qualitative analysis of “nitro” medicines, 
ordinarily, proceeds via indirect tests on account of 
the chemical inertness of the -NO2 group, as distinct 
from the all remaining functional groups. This in-
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volves reactions of pyrolysis or catalytic reduction 
being run firstly (3).
In most cases (regardless of the type of aromat-
ic residue), the modern qualitative pharmacopoe-
ial analysis of Ar-NO2 residues includes reduction 
transformations1 in which the analytes in question 
are preferentially converted to their much more re-
active and analytically traceable nitroso, hydroxyl-
amino, and amino forms or their azoxy and azo de-
rivatives (Scheme 1). Being accompanied by a set of 
sophisticated methodical circumstances, however, 
the method of reduction analysis is difficult to exe-
cute. Also, the reduction tests are not so selective, in-
asmuch as a lot of other functional groups stated to 
give a false positive result (hydrazo-, azo-, azoxy- and 
nitroso-compounds) (6).
Sui generis, however, the reduction of the func-
tional group in question may also be carried out elec-
trolytically in the absence of any relatively expensive 
(and even toxic) reagents or promoters, even in a spe-
1The reduction of nitro groups may also be, in vivo, occur-
ring as a result of metabolic transformations provoked by 
the action of cytochrome P450 in the presence of a com-
petent redox partner (usually NADPH) (under anaerobic 
conditions) or the flavin-dependent NADPH cytochrome 
P450 reductase, as well as by bacterial nitro reductases (in 
the GI tract), and some hepatic oxidoreductases (1).
2As a whole, the mechanism of nitro reduction is very in-
volved and strongly influenced by the nature (biological 
or artificial) of the reaction milieu.
3Many other nitrogen-containing functional groups be-
sides the nitro ones may be involved in a contact with 
the sodium pentacyanoammineferroate, namely: hydra-
zines containing a free NH2 group, aromatic hydrox-
ylamine compounds, nitroso compounds, and several 
amines including pyridine. A positive response to sodi-
um pentacyanonitrosylferrate(II) has also been exhibited 
by thioketones, and some α,β-unsaturated and aromatic 
aldehydes in the presence of hydrogen sulfide.
cific manner viewing the applied potential, current 
density, and electrolytic solvents (7).
The electrochemical reduction of natural and 
synthetic nitro compounds has been drawing con-
siderable attention for more than a century (7,8). In 
the majority of scientific publications, the poten-
tial of those electrochemical (nitroreduction) meth-
ods has been evaluated in the context of their partic-
ipation in the preparative organic chemistry, and in 
the remaining ones, in negligible volume, regarding 
their analytical application (8). 
The electrochemical analysis of aromatic ni-
tro compounds began early in 1934, when F. Feigl, 
V. Anger, and O. Frehden (9) accomplished qual-
itative electrochemical analysis of several artifi-
cial mono- and polynitro aromatic compounds in 
the presence of the titled inorganic reagent (sodi-
um amminepentacyanoferrate(II)3). Shortly thereaf-
ter (10), however, the spot electrochemical test lost its 
practical significance, being substituted by new and 
much more fashionable analytical methods (11-15). 
To complete the potential of Fiegl’s electrochem-
ical test in the field of the pharmaceutical analysis, a 
series of electroreduction spot tests including a phar-
maceutical nitro representative Nitrofural and par-
ticipation of a sodium amminepentacyanoferrate(II) 
reagent have been carried out. For the sake of oper-
ating simplicity, the main study objectives include: 
evaluation of the electrochemical behavior of the ti-
tled medicinal compound in the entourage of the in-
organic Fe complex in question as well as establish-
ing and optimizing of the experimental conditions 
for its qualitative electrochemical determination.
Furthermore, the present work may also be 
considered as a continuation of our earlier studies on 
the qualitative control (spot test analysis) of the bac-
tericidal medicament Nitrofural (5). 
Scheme 1. Mechanism of nitro group reduction2
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MATERIALS AND METHODS 
All chemicals were of analytical grade and used 
as received from commercial sources: sodium nitro-
prusside4 (p.a., Chem-Lab), Nitrofural (98+%, Alfa 
Aesar), Nitrofurantoin (98+%), Chloramphenicol 
(98%, Acros Organics), Metronidazole (99%, Acros 
Organics), 4-nitrotoluene (99%, Sigma-Aldrich), eth-
yl 4-nitrobenzoate (≥98%, Sigma-Aldrich), 4-nitro-
benzoic acid (99%, Alfa Aesar), 4-nitrobenzaldehyde 
(98%, Sigma-Aldrich), sodium acetate anhydrous 
(≥99.0%, Chem-Lab). The solvents ethanol (anhy-
drous), DMSO, and water were received from Fisher 
Scientific. All reactions were performed under ambi-
ent conditions using standard glass depression slides. 
Synthesis of sodium amminepentacyanoferrate 
(II)5: A 250 ml pyrex screw-capped reagent bottle was 
charged with 10 g of sodium nitroprusside, 6.0 g of 
sodium acetate and 75 ml of concentrated NH4OH. 
After keeping the mixture below 5°C overnight (in a 
refrigerator), the bright yellow crystals formed were 
filtered off by suction. Then, the residue was dis-
solved in a minimum amount of cold water and re-
precipitated with a minimum amount of precooled 
ethanol. After filtration, the solid was washed repeat-
edly with 5.0 ml of cold ethanol and dried under a 
stream of dry nitrogen (for about of 2 hours). An in-
significant quantity of the so-obtained crude prod-
uct, marked as Na3[Fe(CN)5NH3]·xH2O, was used for 
the preparation of its 1% aqueous solution.
Experimental procedure: Each glass depression 
was loaded with a drop of a freshly prepared solution 
of 1% sodium amminepentacyanoferrate and a drop 
of 1% solution of Nitrofural in DMSO7. Then the cur-
rent, drawn from a flashlight battery, was passed for 
at least 5 min through the so-obtained mixture2. 
4Synonyms: Sodium pentacyanonitrosoferrate(III), Ni-
pride, Nitropress, used also as a medication in cases of 
acute hypertensive crises.
5The synthetic procedure developed by D. J. Kenney et al. 
has been successfully employed (16) for this purpose.
61% solutions of Nitrofurantoin, Chloramphenicol, and 
Metronidazole in DMSO were also prepared.
7The graphite sticks (0.7 mm in diameter, immersed 1.0 
mm into the test solution, resulting in a working elec-
trode surface of about 5.1mm2 and a current density of 
39.2µA/mm2) were spaced 4.0 mm apart. The anode and 
the cathode sticks were clamped parallel to each other 
and connected to the current source by means of “croco-
Development of red and greenish-blue colored 
zones during the electrolysis should be observed. 
All tests were repeated three times to confirm 
the repeatability of the electrochemical analysis.
Caution!!! All work with ammonia and DMSO 
must be performed under a well-ventilated hood us-
ing protective clothing and gloves.
RESULTS AND DISCUSSION
Microdetection or the so-called “spot test” anal-
ysis of aromatic and heterocyclic nitro compounds 
has been the subject of continuing analytical inter-
est over the last several decades, owing to the steadi-
ly increasing number of nitrogen-containing medi-
cines, polymers, production intermediates, and arti-
ficial raw materials. Up to now, the implementation 
of various analytical methods in the qualitative anal-
ysis of aromatic nitro compounds has been reported 
on in the scientific periodicals. In some of them the 
analysis of nitro compounds has been performed by 
their fusion with diphenylamine or N,N-diethylani-
line (17) or through their pyrolytic-reductive “lysis” 
to nitrous acid (3,18), as well as through their catalyt-
ic reduction to the highly reactive and easily trace-
able hydroxylamine and nitroso forms, or through 
their saponification to the analytically identifiable 
nitrite salts (3). In other papers the qualitative anal-
ysis of nitro compounds has been indirectly accom-
plished by additional, consistently applied, and com-
plicated analytical reactions (19-21).
As to the electrochemical method developed by 
Feigl et. al. (9), it should once again be emphasized 
on due to its originality, effectiveness, and efficiency 
in the qualitative analysis of artificial aromatic nitro 
compounds. The method is unique both by its exper-
imental design, and by its reactant specificity. Fur-
thermore, the methodology of the test allows its easy 
dile” clips and electrical wires, as shown in Figure 1. 
Fig. 1. Schematic representation of the electrolysis cell 
used for the analysis of chemotherapeutic agent Nitrofural
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adaptation and ubiquitous application in the qualita-
tive organic analysis. 
In order to assess the potential of this elec-
trochemical method in the scope of pharmaceu-
tical analysis we have initiated a series of tests for 
investigating the reactivity of the chemothera-
peutic agent Nitrofural in the presence of sodium 
amminepentacyanoferrate.
Actually, as expected, a positive electroanalyti-
cal response was observed when an intermittent cur-
rent, drawn from a 9V battery, passed through the 
tested solution. Surprisingly, however, the electro-
chemical reduction of Nitrofural led to the formation 
of two clearly colored individual zones in the vicin-
ity of both working electrodes, namely: a red colored 
spot surrounding the anodic surface and a greenish-
blue colored one about the cathodic vicinity (Fig. 2). 
The appearance of a red stain has been associ-
ated with the rapid and localized pH changes in the 
composition of the reaction medium during its elec-
trolysis; with changes, which bring about the forma-
tion of a violet-red colored Nitrofual nitronato-qui-
none form. 
Analogous alterations in the coloration of the 
Nitrofual DMSO solution were also registered dur-
ing its mild and intentional alkalization with 0.1 M 
NaOH (2). 
The local changes in pH of the electrolytic solu-
tion were successfully proven and visualized with the 
aid of a moistened indicator paper (part of strip) em-
bedded in the groove of the used glass slide (Fig. 3). 
In this connection, for comparison, the electro-
chemical behavior of the remaining compounds ex-
amined is also shown. Despite the structural simi-
larities, as expected, no other mononitro-containing 
compound, including Nitrofurantoin analog, man-
ifested similar anodic behavior – a behavior, which 
should emphasize the specificity of the present elec-
trochemical method towards the tested nitrofurano-
ic medicine.
The electrochemical changes in the Nitrofu-
ral analyte about the cathodic surface have been 
demonstrated in an irrefutable way by the reduc-
tive transformation of its nitro functional to a re-
active intermediate, which is capable of dyeing the 
used Na3[Fe(CN)5NH3] complex (Fig. 4). Here, com-
plex-formation reactions between the inorganic salt 
used (which is also stated as an effective complexing 
agent) and in situ generated reduced Nitrofural forms 
would be realized (9,16).
In order to justify the above-proposed mecha-
nism and exclude a possible presence of false-posi-
tive reactions, additional tests were performed with 
respect to all reactant species utilized. 
As expected, none of the reagents used, have 
been shown to give such a bicolor “positive” re-
sult. A negative response has also been detect-
ed even at the electrolysis of larger amounts of the 
Na3[Fe(CN)5NH3] salt used, where oxidation-reduc-
tion reactions associated with decomposition of the 
of the pentacyanamine complex and the formation of 
Prussian blue salt may have taken place (16).
Moreover, the negative controls give also evi-
dence that none of the medicines used has been con-
taminated with their partially reduced nitro forms - 
forms, which can occur as a result of their partial bi-
Fig. 2. A photograph illustrating the appearance of two different colored zones in the space around the working electrodes
Fig. 3. Photograph illustrating the differences in the val-
ues of pH in the peri-electrodic spaces obtained during the 
electrolysis process
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ological contamination during sampling or errone-
ous storage (see Footnote 1).
CONCLUSION
The present article describes a simple, rapid, 
and highly specific electrochemical method for de-
tection of the chemotherapeutic agent Nitrofural in 
the presence of sodium amminepentacyanoferrate 
(II). In a series of experiments, the proposed electro-
colorimetric test has proven its reliability and effi-
ciency in the qualitative analysis of the medicine in 
question. The presented method differs from the ex-
isting spot test approaches by being completely de-
fined by a set of experimental circumstances, name-
ly - by the formation of two clearly colored distinct 
zones in the vicinity of the working electrodes; a red 
colored spot around the anodic surface and a green-
ish-blue colored one about the cathodic area.
Although simple, the method presented ap-
pears to be more reliable and specific regarding the 
used Nitrofural analyte being indifferent towards all 
of the remaining tested nitro compounds (Nitrofu-
rantoin, Chloramphenicol, Metronidazole, 4-Nitro-
toluene, Ethyl 4-nitrobenzoate, 4-Nitrobenzoic acid, 
and 4-Nitrobenzaldehyde). 
Moreover, it requires the usage of only one inor-
ganic reagent, Na3[Fe(CN)5NH3], which can either be 
obtained easily or purchased. 
Being accurate, reproducible, and specific, the 
presented method seems to be completely applica-
ble and suitable for the routine pharmaceutical qual-
ity control (second identification analysis) of the raw 
drug substance Nitrofural.
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